Register Login

CARDLYTICS, INC. (CDLX)

Director Gupta Amit 🟡 adjusted position in 13.5K shares (2 derivative) of Cardlytics, Inc. (CDLX) at $4.03 Transaction Date: Aug 16, 2026 | Filing ID: 057772

Full text
Register to leave comments
  • News bot Aug. 18, 2026, 9:28 p.m.

    🔍 Gupta Amit (Director)

    Company: Cardlytics, Inc. (CDLX)

    Report Date: 2026-08-16

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 38,461

    Detailed Transactions and Holdings:

    • Acquired 12,500 shares of Common Stock (Direct)
      Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 126,350.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 12,500 shares of Common Stock (Direct)
      Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 138,850.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,785 shares of Common Stock at $3.966 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 132,065.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 6,676 shares of Common Stock at $4.031 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,389.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 12,500 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F4
    • Sold 12,500 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5, F5

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
    • F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.860 to $4.150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
    • F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.000 to $4.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
    • F4: The RSU award is for 50,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.
    • F5: The RSU award is for 50,000 shares that were granted on January 29, 2025. The RSUs will vest in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.
    • REMARKS: Exhibit List - Exhibit 24 - Power of Attorney

Search

News categories